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Abstract.  Purine analogues were used in this study to 
dissect specific steps in the mechanism of action of 
nerve growth factor (NGF).  Protein kinase N  (PKN) is 
an NGF-activated serine protein kinase that is active in 
the presence of Mn  ÷÷. The activity of PKN was in- 
hibited in vitro by purine analogues,  the most effective 
of which was 6-thioguanine  (apparent K~  =  6 #M). 
Several different criteria indicated that 6-thioguanine  is 
not a general inhibitor of protein kinases and that it is 
relatively specific for PKN.  For instance,  it did not 
affect protein kinases A  or C  and was without effect 
on the overall level and pattern of protein phosphory- 
lation by either intact or broken PC12 cells. Since pu- 
rine analogues rapidly and effectively enter cells, they 
were also assessed for their actions on both transcrip- 
tion-dependent and -independent responses of PC12 
cells to NGE  NGF-promoted neurite regeneration was 
reversibly suppressed by the analogues and at concen- 
trations very similar to those that inhibit PKN.  Com- 
parable concentrations of the analogues also blocked 
NGF-stimulated induction of ornithine decarboxylase 
activity. In contrast to its inhibition of neurite regener- 
ation and ornithine decarboxylase induction,  6-thio- 
guanine did not suppress NGF-dependent induction of 
c-los mRNA expression.  Thus,  purine analogues such 
as 6-thioguanine appear capable of differentially sup- 
pressing some, but not other actions of NGE  These 
findings suggest the presence of multiple pathways in 
the NGF mechanism and that these can be dissected 
with purine analogues.  Moreover, these data are com- 
patible with a  role for protein kinase N  in certain of 
these pathways. 
S 
INCE the characterization of nerve growth factor (NGF) ~ 
(27) as a neurotrophic agent necessary for the develop- 
ment and function of certain peripheral and CNS neu- 
rons (11, 21, 26, 32), many events in its mode of action have 
been revealed (cf. reference 25 for review), but we are still 
far from a complete understanding  of the entire process. The 
biological effects of NGF comprise both transcription-de- 
pendent 05, 24) and -independent  responses (4, 18). To pro- 
vide neuronal  differentiation  and trophic support, these re- 
sponses must be coordinated in the cell by means that are still 
unknown.  In this regard, many studies have been performed 
with the PC12 rat pheochromocytoma cell line (13), a model 
system that has been extensively  used to examine the NGF 
mechanism of action. 
A parameter that is likely to be causally involved in many 
of the events controlled by NGF in the target cell is the regu- 
lation of protein phosphorylation. It is well-documented that 
NGF,  like  many  other  growth  factors,  promotes  rapid 
changes in the phosphorylation of specific cellular proteins 
1.  Abbreviations  used in  this paper:  2-AP, 2-aminopurine;  NGF,  nerve 
growth factor; ODC,  ornithine  decarboxylase;  PKA, cyclic AMP-depen- 
dent  protein  kinase;  PKC, Ca++/phospholipid-dependent  protein  kinase; 
PKN,  protein kinase N; 6-TG, 6-thioguanine. 
(1, 18, 19, 34), as well as regulation  of several different pro- 
tein kinase activities (2, 8,  19, 23, 25, 33, 35). 
In the present work we have further investigated the possi- 
ble functional role of a previously described (2, 35, 36, 39). 
NGF-regulated serine protein kinase, designated  protein ki- 
nase N (PKN). This enzyme is rapidly activated by NGF in 
PCI2 cells (2, 35) as well as in several nonneural  cell lines 
that possess functional NGF receptors,  but that, unlike PC12 
cells, lack morphological and a variety of additional responses 
to the factor (39).  In vitro, PKN uses histone HF1, tyrosine 
mono-oxygenase,  and ribosomal $6 protein as substrates  (2, 
35), is soluble,  is not inhibited  by Mn  ++, and does not re- 
quire Ca  ++, cAMP or other cofactors.  As demonstrated by a 
variety of criteria, PKN is distinct from other well-character- 
ized protein kinases (2, 35, 36).  Partial  isolation  of the en- 
zyme has been achieved by FPLC ion-exchange  and gel ex- 
clusion chromatography (36) and rapid methods for the partial 
purification  and cell-free assay of this kinase from multiple 
samples have been developed (39). 
One potential approach to assessing the functional  role of 
PKN is to use agents that selectively inhibit its activity. We 
report here that purine analogues can effectively block PKN 
activity. Moreover, these compounds differentially  suppress 
© The Rockefeller University Press, 0021-9525/89/11/2395/9 $2.00 
The Journal of Cell Biology, Volume 109, November 1989 2395-2403  2395 some, but not other, transcription-dependent and -indepen- 
dent responses of PC12 cells to NGF and do so with poten- 
cies  similar to those  with which they  inhibit PKN.  Such 
findings both suggest a potential role for PKN in the NGF 
mechanism of action and indicate the existence of multiple, 
separable pathways  in this mechanism. 
Materials and Methods 
Materials 
Purine analogues were purchased from Sigma Chemical Co.  (St.  Louis, 
MO).  Stock solutions (1-100 mM) were prepared in RPMI  1640 medium 
or in water (both adjusted to pH 7.4). In some cases, solubility was achieved 
by heating the compounds in a boiling waterbath. Histone HFI (lysine rich) 
was purchased from Organon Teknika-Cappel (Malvern, PA). 
Cell Culture 
PCI2 cells were cultured as previously described on collagen-coated culture 
dishes in RPMI  1640 medium supplemented with  10%  heat inactivated 
horse serum and 5% FBS (13). Where specified, mouse submaxillary NGF 
(31) was directly added to cultures from a stock of 250 t~g/ml.  In some ex- 
periments,  various purine analogues were added directly to the medium 
from concentrated stocks prepared in RPMI  1640 medium. 
Partial Purification and Assay of  PKN 
This was carried out as previously described (35, 39). Briefly, cultures (100- 
nun dishes) were washed twice with a Hepes-lmffered modified Krebs-Ringer 
solution (pH 7.4) and the cells were scraped in 300/~l of ice-cold harvest 
buffer (50 mM Hepes, pH 7.4, 2 mM EGTA, 10 mM NaE 10 mM MnCh, 
2 mM PMSE  100 KIU/ml Trasylol), sonicated, and centrifuged at 4°C for 
15 rain at 60000 rpm in an ultracentrifuge (model TL-100; SN-941 rotor; 
Beckman Instruments, Inc., Paio Alto, CA). Soluble proteins were loaded 
onto Mono S cation exchange resin mini-columns (500 pl of resin packed 
in 1 nd disposable syringe) mounted on a Super Separator-24 vacuum filtra- 
tion system (Amersham Corp., Arlington Heights, IL) and activity was eluted 
as  follows.  Flow-through  fractions were eluted,  the columns  were each 
washed  with  5  ml of buffer A  (extraction buffer,  without Trasylol  and 
PMSF), and then with 2 mi of 50 mM NaCI in buffer A; the N-kinase activ- 
ity was eluted with 2 ml of 300 mM NaCI in buffer A. This step eliminates 
,~80-90%  of total protein and '~50% of histone-phosphorylating activity 
in the cell extract, with high recovery of PKN activity. Aliquots of the PKN- 
enriched fraction (40/~1,  1-4/ag of protein) were mixed with 10 ~tl of a solu- 
tion containing 5-10 ~tg of histone HFI  and  10 mM  MnCI2.  The phos- 
phorylation assay was started by the addition of 15/~1 of a solution contain- 
ing I ~tCi of [7-32p] ATP (3,000 Ci/mmol; New England Nuclear, Boston, 
MA) and 50 ;tM ATP. This mixture was incubated for 10 min at 37°C and 
the reaction was stopped by the addition of 30 ~tl of 4× concentrated elec- 
trophoretic sample buffer (35). Samples were incubated for 5 rain at 95°C 
and then  subjected to  nitrocellulose  slot-filtration to  separate  the phos- 
phorylated histone from free [7-32p] ATP (39). Single slots were excised 
and assessed for radioactivity by liquid scintillation counting. Blanks were 
determined from samples incubated in parallel without the substrate (his- 
tone) or without the PKN fraction. Purine analogues were directly added 
to the kinase assay from concentrated stocks. Experimental values are ex- 
pressed as "PKN activity/dish", i.e., total radioactivity (cpm) incorporated 
into the histone (less blanks) by the entire PKN-enriched fraction, obtained 
from one cell culture dish. 
Assay of cAMP-dependent Protein Kinase (PKA  ) and 
CW+/Phospholipid-dependent  Protein Kinase (PKC) 
PKA. Cell extracts were prepared in buffer B (15 mM Na phosphate buffer, 
pH 6.5, 25 mM Mg acetate, pH 6.5, 15 mM NaF, 2 mM PMSE 100 KIU/ml 
Trasylol) as described above for PKN.  Aliquots of the extracts (10-30 ~tg 
of protein) were mixed with 20 pg/nssay of histone HI S in 65/tl final volume 
of buffer A  +  10/zM cAMP (7).  1 /~Ci of [3,-32p]ATP  (3,000Ci/mmol; 
New England Nuclear) in ATP (50 itM final concentration) was added and 
the phosphorylating reaction was performed at 37°C for 10 rain. Samples 
were then resolved by SDS-PAGE (6-12 % linear acrylamide gradients) and 
processed for autoradiography. 
PKC. This was performed as for PKA with the exception that cell extrac- 
tion was in buffer C (25 mM Tris-CI, pH 7.4, 1 mM EDTA,  1 mM EGTA, 
1 mM DTT, 6  mM Mg acetate, 2  mM PMSF,  100 KIU/mi Trasylol) and 
the phosphorylating reaction was performed in buffer C  +  1.5 mM CaC]2 
and with 5  pg/ml phosphatidylserine and 0.5 ~tg/ml diolein (19). 
Phosphorylation Studies 
These were performed as previously described (16). Briefly, cells (in 35-mm 
dishes) were incubated with or without NGF in Hepes-buffered modified 
Krebs-Ringer solution (pH 7.4), in the presence of 100/~Ci/ml of [32p]or- 
thopbosphate for 2-4 h. When indicated, the cultures were preincubated for 
1 h with 6-thioguanine (100/~M and 500 ttM) or adenine (5 raM) and then 
subjected to phosphorylation in the continued presence of these drugs. Cells 
were scraped off the dishes in 200/~1 of sample buffer and aliquots (contain- 
ing equal  amounts  of TCA-precipitable radioactivity)  were  subjected to 
SDS-PAGE on 6-12% acrylamide gradient gels (30 cm long). 
Ornithine Decarboxylase (ODC) Activity 
This was measured by methods slightly modified from those previously de- 
scribed (14). PC12 cells were cultured overnight on 35-mm dishes in RPMI 
containing 1% horse serum. NGF was then added for 6 h at a final concen- 
tration of 50 ng/ml in the presence or absence of purine analogues. The col- 
tures were then washed free of medium and were frozen on dry ice until 
assay. At this time, they were scraped in 400/~1 of 50 mM Tris-Cl, (pH 7.4), 
1 mM EDTA, 5 mM DTT, 0.1 mM pyridoxal phosphate, and 0.5 mM L-or- 
nithine. The extracts were sonicated on ice for 5 s and centrifuged for 15 min 
at 12,000 g.  ODC activity was measured in supernatant fractions as de- 
scribed (14).  [1J4C]  U,L-ornithine (specific activity 53 mCi/mmol;  New 
England Nuclear)  was  used at 0.1-0.4/tCi/assay.  Released  [14CO2] was 
trapped in 100 ~tl of Protosol (New England Nuclear) absorbed on filter pa- 
per (GF/C; Whatman, Inc., Clifton, NJ) and radioactivity was assessed by 
liquid scintillation counting. Assays were performed using 100-300/tg of 
protein per sample. 
Neurite Regeneration Studies 
PCI2  cells were pretreated with NGF for  1-2 wk and then passnged for 
regeneration on coUagen-coated 35-ram tissue culture dishes in complete 
medium in the presence or absence of NGF (50 ng/ml), with or without the 
specified purine analogues. The cultures were then observed 1 d later and 
scored for proportion of neurite-bearing cell clamps as detailed elsewhere (4). 
Northern Blot Analysis of  c-fos mRNA 
Cells were grown in 100-ram dishes and pretreated where applicable for I h 
with the appropriate  final concentrations of purine analogue.  NGF was 
added for 1 h and the plates were chilled, washed with cold buffered saline, 
and immediately used for isolation of total cellular RNA as previously de- 
scribed  (6).  15  ~tg  of  total  RNA  per  sample  were  separated  on  1% 
agarose-formaldehyde gels and transferred to nitrocellulose as described 
(29).  The nitrocellulose blots  were prehybridized,  hybridized with 32p_ 
labeled probe (Pst I fragment of plasmid p-fos-l; reference 9), and washed 
as described elsewhere (28). To confirm equality of RNA loaded, the blots 
were  boiled  and  rehybridized  with  probe  to  glucose-6-phosphate  de- 
hydrogenase (28). 
Protein Determination 
Protein concentrations were determined by the method of Bradford  (3), 
using reagents and protocols purchased from Bio~Rad Laboratories (Cam- 
bridge, MA) and with BSA as standard. 
Results 
In Vitro Inhibition of PKN by Purine Analogues 
The data in Fig.  1 illustrates  that PC12 cell extracts  highly 
enriched for PKN (see Materials and Methods) catalyze the 
phosphorylation  of historic  HFI  in the  presence  of Mn  ++ 
and that this activity is enhanced for extracts  derived from 
NGF-treated cells. In assessing agents that might modulate 
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Figure L Basal and NGF-activated PKN activity is inhibited by pu- 
rine analogues. PC12 cells were treated for 10 min with or without 
NGF (50 ng/ml final concentration)  directly  added to the culture 
medium.  Extraction,  partial purification,  and assay of PKN were 
performed as described  in  Materials  and  Methods.  Purine  ana- 
logues were added directly to the kinase assay. Approximately 900 
~tg of soluble protein was loaded on Mono S minicolumns. The data 
represent average values  +  SEM (n  =  4). 
PKN kinase activity, we tested purine analogues. A rationale 
for this is that one such analogue, 2-aminopurine (2-AP) has 
been reported to be a relatively selective protein kinase in- 
hibitor (10);  The data in Figs.  1 and 2 A and Table I show 
that purine analogues can effectively block PKN activity in 
vitro. In contrast to 2-AP and adenine which block PKN with 
apparent  K~  values  of ~2  mM,  6-thioguanine  (2-amino- 
6-mercaptopurine; 6-TG), inhibited PKN with a  >100-fold 
lower apparent ~  of '~6 #M.  The corresponding nucleo- 
side 6-thioguanosine was also an effective inhibitor with an 
apparent Ki ,x,40 #M (Fig. 2  and Table I). 2-AP and 6-TG 
suppressed both NGF-stimulated as well as basal PKN activ- 
ity (Fig.  1). 
Even at very high concentrations of 2-AP or 6-TG, the ki- 
nase activity in  extracts enriched  for PKN was not com- 
pletely inhibited (see Figs.  1 and 2). We still do not know 
if this is due to contamination of the PKN preparation by 
purine-insensitive ldnases or to a resistant isoform of PKN. 
Specificity with which Purine Analogues Inhibit PKN 
Several different types of experiments were performed to de- 
termine the specificity with which purine analogues inhibit 
PKN activity. In each case, 6-TG was compared with either 
2-AP or adenine. Fig. 2 B shows the effects of 6-TG and 2-AP 
on phosphorylation of histone HF1 in the presence of Mn  ~ 
by unfractionated PC12 cell extracts. In contrast to its potent 
blockade of partially purified PKN activity, 6-TG had no ap- 
parent effect on overall activity in the extracts, even at con- 
centrations of  up to 1 mM. On the other hand, 2-AP inhibited 
such activity with an ICso in the range of 5 raM. When the 
endogeneous phosphorylating activity of cell extracts was 
tested under the usual conditions, but in the absence of ex- 
ogeneous substrate (histone), neither 2-AP (7 mM), adenine 
(3  raM),  or 6-TG (600  pM)  inhibited  the overall level of 
phosphate incorporation or affected the pattern of protein 
phosphorylation (as assessed by SDS-PAGE autoradiogra- 
phy; data not shown).  As an additional  test of specificity, 
6-TG and 2-AP were evaluated for their effects on protein ki- 
nase A and protein kinase C activities. At levels of up to 500 
#M, 6-TG had no effect on either kinase; 2-AP was similarly 
without effect at up to 5 mM (data not shown). 
Purine derivatives are known to penetrate intact cells very 
quickly (30). Therefore the purine analogues were addition- 
ally tested for effects on phosphorylation in intact cells. The 
data in Fig. 3 reveal that during 3 h of incubation, 6-TG (500 
/~M) had no significant effect on the overall incorporation of 
32p-labeled  phosphate into  macromolecules,  whereas  ade- 
nine (5 mM) inhibited this parameter by ~50%.  As illus- 
trated by Fig.  4,  the phosphoproteins labeled under these 
conditions were analyzed by SDS-PAGE. There were no oh- 
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Figure  2. Effect of 2-AP and 6-TG on histone HFI phosphorylation 
by PKN and by unfractionated  PC12 cell extracts. Extracts were 
prepared from PC12 cells as described in Materials and Methods. 
For the data in A, PKN was partially purified by chromatography 
on a mini-Mono S column (•450/zg  of soluble protein was loaded) 
and equal aliquots were assayed for PKN activity in the presence 
of the indicated concentrations of 2-AP and 6-TG. For the data in 
B, aliquots of the unfractionated extract (containing approximately 
the same amount of protein as that used for partial purification of 
PKN) were assessed for phosphorylation  activity under the same 
conditions used to measure PKN activity and in the presence of the 
indicated concentrations of additives. In each case the substrate was 
histone HFI. Values represent the total specific phosphorylation ac- 
tivity per sample and are expressed as means + SEM (n = 4). The 
asterisks on the ordinate represent the control values of PKN activ- 
ity in the absence of purine analogues. 
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Activity 
IC5o for PKN 
Analogue  inhibition 
mM 
2-Amino-6-mercaptopurine  (6-TG)  0.006 
6-Thioguanosine  0.04 
2-Amino-6-methylmercaptopurine  0.4 
2-AP  2.0 
Adenine (6-aminopurine)  2.0 
Adenosine  2.5 
The experiment  was performed  as described  in the legend to Fig. 1. The com- 
pounds were added directly to the PKN enzymatic  assay. Values are average 
of two independent  experiments  each performed on duplicate samples. The 
standard deviations  were <15%. 
served effects of 6-TG on the phosphoproteins that can be 
resolved at this level of analysis. Adenine also had few evi- 
dent effects but did appear to somewhat decrease the incor- 
potation of phosphate into a band at ,050,000 Mr. Moreover, 
neither 6-TG nor adenine had any observable effect on NGF- 
promoted  changes  in  protein  phosphorylation  that  occur 
under these conditions.  This  includes enhanced phosphate 
incorporation into MAP 1.2, a high molecular weight micro- 
tubule-associated protein (1), into tyrosine hydroxylase (18), 
and into several presently unidentified species of apparent 
molecular masses of ,,o64, 55, and 20 kD. Two-dimensional 
gel electrophoresis was also performed on similar samples 
and the general pattern of protein phosphorylation was found 
to be unaffected by the presence of purine analogues (data not 
shown). 
Effect of Purine Analogues on PKN Activation in 
Intact Cells 
Past findings have indicated that PKN is itself activated via 
the actions of other protein kinases (2, 35, 36). We therefore 
Figure 3.  Effect of 6-TG and 
adenine on the incorporation 
of phosphate  by  PC12  cells. 
Sister cultures were preincu- 
bated for 1 h in the presence of 
either no drug (CONTROL), 
500 #M  6-TG or 5  mM ade- 
nine.  They  were  then  incu- 
bated with the same additives 
at 370C for an additional 2 h in 
a  Hepes-bnffered phosphate- 
free saline in the presence of 
100 #Ci/ml of [32p]orthophos- 
phate, with or without NGE After incubation, the cells were washed 
to remove external phosphate and were harvested in 500 #1 of SDS 
sample buffer.  Aliquots (50 #1) were assessed (by liquid scintilla- 
tion counting) for radioactivity present either in the total extract or 
in TCA-precipitable material. In each case, the values of the latter 
were corrected for total phosphate uptake in the cells by normal- 
izing to radioactivity in the total extract. TCA-precipitable counts 
accounted for ,o5 % of the total radioactivity in the extracts (`o 106 
cpm/culture). Values are expressed as normalized TCA-precipitable 
counts per culture relative  to that in control, nontreated cultures and 
are given as averages +  SEM (n  =  3). Comparable results were 
achieved in three independent experiments. 
Figure 4. Effects of 6-TG and adenine on the patterns of basal and 
rapidly NGF-regulated  protein phosphorylation in PC12 cells. Cul- 
tures were treated as described in the legend of Fig. 3 except that 
cells treated with 100 #M 6-TG were also tested and harvesting was 
in 400 #1 of sample buffer.  Aliquots containing equal numbers of 
cpm (50,000) were subjected to SDS-PAGE and autoradiography as 
described in Materials and Methods.  Numbers on the right rep- 
resent  the  position of molecular mass  standards  (given  as  M, 
x  10-3). 
investigated the ability of purine analogues to affect activa- 
tion of PKN by NGF in intact cells. PC12 cells were treated 
for 10 min with or without NGF in the presence or absence 
of 10 mM 2-AP or 500 #M  6-TG (both concentrations are 
NGF  NGF 
Figure 5.  Effect of 2-AP and 
6-TG on NGF-promoted acti- 
vation of PKN in intact PCI2 
cells. Replicate cultures were 
treated  for  10  min  with  or 
without NGF and in the pres- 
ence  or  absence  of  10  mM 
2-AP or 500  /zM  6-TG.  The 
cells were then rapidly washed 
and  extracts  were  prepared 
and used for the partial puri- 
fication and assay of PKN as 
described in Materials and  Methods.  Approximately 200  #g of 
soluble protein was loaded on each Mono S minicolumn. Values 
represent the total specific phosphorylation activity per sample and 
are expressed as means  :l: SEM (n  =  4). 
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were pretreated  for 10 d with NGF (50 ng/ml) and then passaged for regeneration on collagen-coated 35-ram tissue culture dishes in.RPMI 
1640 medium containing 1% horse serum and in the presence or absence of NGF (50 ng/mi), with or without purine analogues.  (a-d) 
Cells are shown 24 h after they were replated  for regeneration;  (a) in the presence of NGF; (b) without NGF; (c) with NGF and 30/~M 
6-thioguanine; (d) with NGF and 5 mM adenine.  After the cells were cultured for 24 h with NGF in the presence of purine analogues, 
they were rinsed and the medium was replaced with fresh medium containing only NGF.  Cells are shown 2 d after washout of 30/~M 
6-thioguanine (e) or of 5 mM adenine (f). 
above the IC5o  values  for in vitro  inhibition  of  PKN). The 
cultures  were then  rapidly  washed free  of  the  drugs and as- 
sessed  for  PKN  activity.  Under these  conditions,  since  the 
purinc  analogues were removed and  any  remaining material 
was highly  diluted  during the  partial  purification  and assay 
of the enzyme, any noted effects  were due to interference 
with  activation  of  PKN in  situ,  rather  than  due  to  direct  inhi- 
bition during the assay.  The data in Fig.  5  show that 2-AP 
suppressed activation of PKN by NGF in intact cells while 
6-TG did not. 6-TG failed to block PKN activation even after 
4 h of preincubation with the cells (not shown). In contrast, 
when the  NGF-activated  PKN was  partially  purified  from  cells 
that  had  been incubated  for  4 h with 6-TG, this  activity  was 
inhibitable in vitro by both 2-AP and 6-TG (data not shown). 
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directly inhibiting PKN, also blocks a phosphorylation event 
in the NGF-regulated pathway that leads to PKN activation. 
In contrast 6-TG is more specific for PKN and does not block 
the activation pathway. This interpretation is consistent with 
the  above-described differences in  apparent  specificity of 
2-AP and 6-'1"(3 for inhibition of histone phosphorylation by 
unfractionated cell extracts. 
In light of the effects of purine analogues on PKN activity, 
these compounds were assessed for their effects on various 
biological responses to NGE 
Effect of Purine Analogues on Neurite Regeneration 
When neuronally differentiated PC12 cells are mechanically 
deprived of their neurites and then replated, they undergo 
NGF-promoted neurite regeneration within 1 d (Fig. 6). This 
rapid effect  does not require RNA synthesis (4). Fig. 6 shows 
the effect of inclusion of 30/~M 6-TG or 5 mM adenine dur- 
ing such regeneration. In both cases, neurite outgrowth was 
suppressed, even though the cells appeared well-attached to 
the substrate and in good condition. Further evidence for the 
latter was that the effect was reversible; washout of the drugs 
was followed within 1-2 d by the appearance of normal neu- 
rites (Fig. 6). 
Fig. 7 shows a dose-response curve of the effect of various 
purine analogues on PC12 cell neurite regeneration. Table II 
summarizes  the  apparent IC5o values  for these and  addi- 
tional analogues. As in the case of PKN inhibition, 6-TG is 
by far the most effective compound with an IC50 of '~ 3 #M. 
2-AP and adenine, as well as several other analogues, exhibit 
IC50 values in the range between 1 and 10 mM. Both purine 
and guanine were without effect  at the highest concentrations 
of each that could be tested (10 and 0.5 mM, respectively). 
Finally, 2-amino-6-methylmercaptopurine, similar to its effect 
on PKN inhibition in vitro (Table I), had an intermediate ac- 
tivity with an ICso of ,x, 200 #M (Table II). 
Effects of  Purine Analogues on Induction of ODC 
Activity in Intact PC12 Cells 
NGF  treatment promotes a  large  (>10-fold)  induction of 
ODC activity within 4-6 h of addition to PC12 cell cultures 
(14). In contrast to NGF-promoted neurite regeneration, this 
action is dependent on RNA synthesis (5) and appears to be 
100 
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Figure 7. Dose-response rela- 
tionships for effects of purine 
analogues on NGF-dependent 
neurite  regeneration.  PC12 
cells were pretreated for 10 d 
with NGF (50 ng/ml) and then 
passaged for regeneration on 
collagen-coated 35-mm tissue 
culture dishes in RPMI medi- 
um containing  1%  horse  se- 
rum  with  NGF  (50  ng/ml), 
with or without the indicated 
concentrations of purine analogues. Neurite-bearing cell clumps 
were scored at 18-24 h after replating. Values are expressed relative 
to the total proportion of cell clumps regenerating neurites in the 
absence of drugs (80-95%). At least 100 cell clumps were scored 
per sample. -4~, adenine; --i-, 6-TG; -cr-, 2-AP; -~-, 6-MTG; -~-, 
purine. 
Table II. Effect of Various Purine Derivatives on PC12 Cell 
Neurite Regeneration 
IC5o for neurite 
Drug  regeneration 
mM 
2-Amino-6-mercaptopurine (6-TG)  0.003 
2-Amino-6-methylmercaptopurine  0.2 
6-Cyanopurine  1.0 
Adenine (6-aminopurine)  2.0 
6-Mercaptopurine  2.5 
Theophylline  2.5 
2, 6-Diaminopurine  3.0 
2-AP  7.0 
Guanine (2-amino-6-hydroxypurine)  >0.5 
2-Hydroxy-6-Mercaptopurine  (6-thioxanthine)  >10.0 
Purine  >20.0 
PCI2 cell neurite regeneration  was carried out as described  in the legend to 
Fig.  7 with or without various concentrations  of the above compounds.  For 
each compound, dose-response curves were generated and these were used to 
determine  the  IC5o values.  For guanine,  6-thioxanthine  and  purine,  values 
given were the highest concentrations that could be tested due to limitation of 
solubility. 
due to enhanced transcription of the ODC gene (12). Fig. 8 
shows the effect  of NGF added along with various concentra- 
tions of 6-TG or 2-AP. 6-TG inhibited the induction of ODC 
activity with what appears to be a biphasic dose-response 
curve. About 70 % of the induction was blocked with an ap- 
parent IC50 <10 #M. The remaining induction was blocked 
only at concentrations >1 mM. 2-AP also showed a biphasic 
dose response curve. In this case, the induction was consis- 
tently somewhat enhanced by concentrations of up to 5 mM 
and was effectively  blocked at 10 mM. Adenine and diarnino- 
purine also effectively suppressed the induction of ODC. A 
60 % inhibition was observed with 5 mM adenine and total 
inhibition with 10 mM diaminopurine. Uric acid, the degra- 
dation product of  purine derivatives, was without effect  at the 
highest concentrations that could be tested (500 #M). 
Effect of  Purine Analogues on Induction of 
c-los mRNA 
Another early transcription-dependent action of NGF is the 
induction ofc-fos (12). Zinn et al. (41) have shown that 2-AP 
suppresses the induction of this proto-oncogene in human 
MG63 osteosarcoma cells. Fig. 9 illustrates the effects  of  2-AP 
and 6-TG on c-fos mRNA levels in PC12 cells treated with 
NGE As in MG63 cells, 2-AP (10 mM) inhibits the increase 
in c-fos mRNA. For the experiment shown in Fig. 9, there 
was a 70% blockade of induction. In three additional inde- 
pendent experiments (not shown), inhibition appeared to be 
nearly complete. In contrast, 6-TG (100 #M in Fig. 9) did 
not inhibit the induction of c-fos mRNA by NGE and in fact, 
appeared  to  enhance  this  effect.  Other  experiments  (not 
shown) revealed that, as in the presence of NGF alone (12), 
the c-fos mRNA induction was transient in the presence of 
6-TG and NGF, peaking at ool h and being undetectable by 
4 h of treatment. 
Discussion 
The purpose of the present work was to investigate how NGF 
promotes and coordinates the diverse group of responses that 
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Figure 8.  NGF-induced ODC  activity  is  inhibited by 2-AP and 
6-TG. PC12 cells were cultured on collagen-coated 35-mm tissue 
culture dishes in RPMI 1640 medium containing 1% horse serum. 
NGF (50 ng/ml) was added for 6 h in the presence or absence of 
the indicated concentrations of 2-AP or 6-TG. [1-m+C]X>,L-ornithine 
was used at 0.45/~Ci/assay. Values are averages of determinations 
on replicate cultures =1= SEM (n =  3). The asterisks represent the 
value of  ODC activity in PC12 cells not cultured with NGF and the 
closed circle represents the activity without added analogue. 
it elicits in its target cells. To this end, we have used purine 
analogues to modulate and dissect specific effects of NGE 
Our data show that the purine analogue 6-TG can effec- 
tively block certain responses to NGF while sparing others. 
For example, neurite regeneration was suppressed by 6-TG 
while  several  additional  transcription-independent  NGF- 
promoted responses,  namely activation of PKN itself and 
enhanced phosphorylation of specific proteins, were appar- 
ently unaffected. This was also the case for transcription- 
dependent actions of NGF; 6-TG suppressed the induction of 
ODC  activity  but  did  not  inhibit  the  induction  of c-fos 
mRNA. 
One mechanism that could account for the effects of 6-TG 
on NGF responses that is consistent with our observations 
is interference with the activity of PKN. Thus, 6-TG inter- 
feres with PKN activity in a cell-free assay and does so with 
a potency similar to that with which it blocks biological re- 
sponses in intact cells.  Moreover, at the levels of analysis 
used here, 6-TG did not detectably affect protein kinase ac- 
tivities other than PKN. 
Aside from its effects on PKN, there are of course addi- 
tional cellular actions of 6-TG that merit consideration in 
light of our present observations. Most notably, 6-TG is a po- 
tent cytotoxic agent. However, the toxic effects of this com- 
pound on PC12 cells were not detectable before 2-3 d  of 
treatment, that is, well beyond the appearance of the param- 
eters that were assessed. Also, in the case of neurite regener- 
ation, in which treatment with the drug was for 1 d, the in- 
hibitory effects were reversed after washout. Perhaps related 
to its lethal actions, 6-TG is incorporated into cellular DNA 
and alters the synthesis and function of RNA and DNA (40). 
Figure 9. Effect of purine analogues on NGF-dependent induction 
ofc-fos. Cells were grown in 100-ram dishes and pretreated where 
applicable for 1 h with the appropriate final concentrations of pu- 
rine analogue. NGF was added for 1 h and the cells were immedi- 
ately used for isolation of total cellular RNA.  15 #g of total RNA 
per sample were separated on 1% agarose-formaldehyde gels and 
transferred to nitrocellulose.  The nitrocellulose blots were pre- 
hybridized, hybridized with 32P-labeled probe, washed, and auto- 
radiograpbed, all as described in Materials and Methods. 
Such effects would, however, seem unlikely to be directly in- 
volved in the blockade of NGF responses. Neurite regenera- 
tion is independent of RNA synthesis (4) while at least one 
transcription-dependent action of NGF, the induction of c-fos 
mRNA, is not blocked by 6-TG. 
Our findings also revealed differences in effect  between 6-TG 
and several other purine analogues. In contrast to 6-TG, 2-AP 
blocked NGF-promoted activation of PKN and,  in agree- 
ment with earlier findings (41), suppressed induction of c-fos 
mRNA.  Studies of the specificities with which these com- 
pounds inhibit cellular protein kinase activity also revealed 
marked differences. At concentrations similar  to those at 
which they affected PKN activity, 2-AP and adenine partially 
inhibited phosphorylation of histone by cell extracts; 6-TG 
was  ineffective in  this  respect.  Finally,  2-AP and  several 
other purine analogues were two to three orders of magni- 
tude less potent than 6-TG in inhibition of PKN activity in 
vitro, and in suppression of neurite regeneration and ODC 
induction. These observations are consistent with the possi- 
bility that compounds such as 2-AP and adenine exert at least 
some of their NGF-inhibitory actions by interfering both 
with the activation and with the activity of PKN. Additional 
suppressive actions of these analogues not shared with 6-TG 
could be due to their lesser specificity as protein kinase in- 
hibitors.  For instance, earlier findings have suggested that 
PKN might itself be activated by phosphorylation via an- 
other NGF-activated protein kinase (2, 35, 36). It is thus con- 
ceivable that 2-AP interferes with this NGF-regulated kinase. 
Several other agents have been found to interfere with re- 
sponses to NGF and it is of interest to compare their actions 
with the effects of purine analogues.  Inhibitors of cellular 
trans-methylation, all of which are adenosine analogues, in- 
terfere with  neurite  outgrowth  and  ODC  induction  (37). 
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all other responses to NGF including rapid tyrosine hydroxy- 
lase phosphorylation (37) and induction  of c-los gene tran- 
scription  (12).  The alkaloid protein kinase inhibitor K-252a 
similarly  differs from purine analogues in that it blocks all 
known responses of PC12 cells to NGF (20, 22). Forskolin 
and cholera toxin have been found to block NGF-dependent 
neurite regeneration (17), but differ from purine compounds 
in that they also suppress tyrosine hydroxylase phosphoryla- 
tion (17) and induce ODC (38). Lithium ion is an additional 
agent that suppresses NGF-promoted neurite outgrowth and 
selectively  interferes  with  the phosphorylation  of chartin 
microtubule-associated  proteins (5). However, this ion does 
not block PKN activity  in vitro (Volontt, C.,  unpublished 
results). 
As noted above,  such agents as trans-methylation inhibi- 
tors and K252-a block all responses to NGF whereas other 
compounds such as purine  analogues affect only selective 
NGF actions.  This suggests a single initial pathway in the 
NGF mechanism followed by a set of divergent pathways. In 
particular, 6-TG appears to dissect out a pathway or set of 
pathways in the NGF mechanism that play necessary roles 
in neurite regeneration and in ODC induction,  but that seem 
distinct  from those that lead to c-los gene activation and to 
rapid phosphorylation  of several intraceUular proteins. 
We have suggested that PKN is activated by NGF-promoted 
phosphorylation, and that 6-TG exerts its inhibitory actions 
on NGF responses through blockade of PKN activity.  One 
may further conceive of a cascade of branching pathways that 
are initiated after NGF binding and that this cascade is driven, 
at least in part, by regulation of various protein kinases. This 
is consistent with the large variety of different cellular  re- 
sponses that are triggered by NGE Activators of protein ki- 
nases such as PICA and PKC have been reported to mimic 
some, but not other responses of cells to NGF (25).  This 
might occur ifPKA and PKC can in turn activate certain, but 
not all, pathways of the NGF mechanism. For instance, both 
of these kinases activate PKN (2, 35, 36). In this light,  it is 
of interest that purine  analogues block induction  of ODC 
brought about by exposure of PC12 cells to a cAMP deriva- 
tive (Volontt, C., and D. Loeb, unpublished  data). 
Our studies have examined the effects of purine analogues 
on NGF responses in a cell culture system.  One might fur- 
ther raise the possibility that excessive accumulation of pu- 
fine derivatives could, with detrimental consequences, also 
interfere with trophic factor actions in the intact organism. 
We thank Federico Negri for his expert technical assistance and Dr. Gior- 
gio Inghirami  for helpful advice on Northern  blotting. 
Supported by National Institutes of Health grant NS 16036 and a March 
of Dimes Basic Research  Grant. 
Received for publication  4  May 1989 and in revised form 10 July  1989. 
References 
I. Aletta, J. M., S. A. Lewis, N. J. Cowan, and L. A. Greene. 1988. Nerve 
growth factor regulates both the phosphorylation and steady state levels 
of  microtubule  associated  protein  1.2  (MAP  1.2).  J.  Cell  Biol. 
106:1573-1581. 
2. Blenis, J., and R. L. Erikson. 1986. The regulation of protein kinase activi- 
ties in PCi2 pheochromocytoma cells. EMBO (Fur. Mol. Biol. Organ.) 
3'. 5:3441-3447. 
3. Bradford, M.  1976.  A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye 
binding. Anal.  Biochem.  72:248-252. 
4. Burstein,  D.  E.,  and  L.  A.  Greene.  1978.  Evidence  for  both  RNA- 
synthesis-dependent  and -independent pathways in stimulation of neurite 
outgrowth  by  nerve  growth  factor.  Proc.  Natl. Acad.  Sci.  USA. 
75:6059-6063. 
5. Burstein, D. E., P. J. Seeley, and L. A. Greene. 1985. Lithium ion inhibits 
nerve growth factor-induced neurite outgrowth and phospborylation of 
nerve growth factor-modulated microtubule-associated proteins. J.  Cell 
Biol.  101:862-870. 
6. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isola- 
tion  by  acid  guanidinium thiocyanate-phenol-chloroform extraction. 
Anal.  Biochem.  162:156-159. 
7. Costa, M., E. W. Gerner, and D. H. Russell. 1976. Cell cycle-specific  ac- 
tivity  of  type  1  and  type  R  cyclic  adenosine  3':5'-monophosphate- 
dependent protein kinases in chinese hamster ovary cells. J. Biol. Chem. 
251:3313-3319. 
8. Cremins, J., J. A. Wagner, and S. Halegoua. 1986. Nerve growth factor ac- 
tion is mediated by cyclic AMP- and CaZ+/pbospbolipid-dependent  pro- 
rein kinases. J.  Cell Biol. 103:887-893. 
9. Curran, T., G. Peters, C. Van Beveren, N. M. Teich, and I. M. Verma. 1982. 
FBJ murine osteosarcoma virus: identification  and molecular cloning of 
biologically  active proviral  DNA. J.  Viral. 44:674-682. 
10. Farreil, P. J., K. Balkow, T. Hunt, and R. J. Jackson. 1977. Pbosphorylation 
of initiation  factor elF-2 and the control of reticulocyte  protein synthesis. 
Cell.  11:187-200. 
IL Goedert, M., U. Otten, S. P. Hunt, A. Bond, D. Chapman, M. Sehlumpf, 
and W. Lichtensteigur.  1984. Biochemical and anatomical effects of anti- 
bodies against nerve growth factor  on developing rat sensory ganglia. 
Proc. Natl. Acad. Sci. USA. 81:1580-1584. 
12. Greenberg, M. E., L. A. Greene, and E. B. Ziff.  1985. Nerve growth factor 
and epidermal growth factor induced rapid transient changes in proto- 
oncogene transcription in PCI2 cells../. Biol. Chem. 260:14101-14110. 
13. Greene, L. A., and A. S. Tischler.  1976. Establishment of a norudrenergic 
clonal line of rat adrenal pheechromocytoma  cells which respond to nerve 
growth factor. Proc. Natl. Acad. Sci. USA. 73:2424-2428. 
14. Greene, L. A., and J. C. McGuire. 1978. Induction of ornithine decarboxy- 
lase by nerve growth factor dissociated from effects on survival and neurite 
outgrowth.  Nature (Lond.). 276:191-194. 
15. Greene, L. A., D. E. Burstein, and M. M. Black.  1982. The role of tnm- 
scription-dependent priming in nerve growth factor-promoted  neurite out- 
growth. Dev. Biol. 91:305-316. 
16. Greene, L. A., R. K. H. Liem, and M. L. Shelanski. 1983. Regulation  of 
a high molecular weight microtubule-associated protein in PCI2 cells by 
nerve growth factor. J.  Cell Biol. 96:76-83. 
17. Greene, L. A., S. A. Drexler, J. L. Connolly, A. Rukestein, and S. H. 
Green. 1986. Selective inhibition of responses to nerve growth factor and 
of microtubule-associate  protein phosphorylation by activators of adenyl- 
ate cyclase. J.  Cell Biol. 103:i967-1978. 
18. Halegoua, S., and J. Patrick.  1980.  Nerve growth factor mediates phos- 
phorylation of specific proteins. Cell. 22:571-581. 
19. Hama, T., K. P. Huang, and G. Guroff. 1986. Protein kinase C as a compo- 
nent of a nerve growth factor-sensitive pbospborylation system in PC 12 
cells. Proc. Natl. Acad.  Sci. USA. 83:2353-2357. 
20. Hashimoto, S. 1988. K-252a, a potent protein kinase inhibitor, blocks nerve 
growth factur-induced neurite outgrowth and changes in the pbospboryla- 
tion of proteins in PCI2h cells. J.  Cell Biol. 107:1531-1539. 
21. Honneger, P., and D. Lenoir. 1983.  Nerve growth factor (NGF) stimula- 
tion of cholinergic telencephalic neurons in aggregating cell cultures. 
Dev. Brain ICes. 3:229-238. 
22. Koizumi, S., M. L. Contreras, Y. Matsuda, T. Hama, P. Lazarovici, and 
G.  Guroff.  1988.  K-252a:  a  specific  inhibitor of the action of nerve 
growth factor on PCI2 cells. J.  Neurosci.  8:715-721. 
23. Landreth, G. E., and G. Rieser. 1985. Nerve growth factor and epidermal 
growth factor-stimulated pbospborylation of a  PC12 cytoskeletally as- 
sociated protein in situ. J.  Cell Biol. 100:677-683. 
24. Leonard, D. G. B., E. B. Ziff, and L. A. Greene. 1987. Identification  and 
characterization of mRNAs regulated by nerve growth factor in PCI2 
cells. Mol. Cell. Biol. 7:3156-3167. 
25. Levi, A., S. Biocca, A. Cauaneo, and P. Calissano. 1988.  The mode of 
action of nerve growth factor in PC 12 cells. Mol. Neurobiol. 2:201-226. 
26. Levi-Montalcini, R.,  and P.  U.  Angeletti.  1968.  Nerve growth factor. 
Physiol. Rev. 48:534-569. 
27. Levi-Montalcini, R. 1987. The nerve growth factor: 35 years later. Science 
(Wash. DC). 237:1154-1162. 
28. Lomhardi, L., E. W. Newcomb, and R. Dalla-Favera. 1987. Pathogenesis 
of Burkitt lymphoma: expression of an activated c-myc oncogene causes 
the tumorigenic conversion of EBV-inf~  human B  lympboblasts. 
Cell. 49:161-170. 
29. Maniatis, T. M., E. F. Fritsch, and J. Sambrook. 1982. Molecular Clon- 
ing. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring 
Harbor,  New York. 545 pp. 
30. Marz, R., R. M. Wohlhueter, and P. G. W. Plagemann. 1979. Purine and 
pyrimidine transport and phnspboribosylation and their interaction in 
overall uptake by cultured mammalian cells. J. Biol. Chem. 254:2329- 
2338. 
31. Mobley, W. C., A. Schenker, and E. M. Shooter.  1972. Characterization 
The Journal of Cell Biology, Volume 109,  1989  2402 and isolation of proteolytically modified nerve growth factor. Biochemis- 
try.  15:5543-5552. 
32. Mobley, W. C., J. L. Rutkowski, G. I. Tennekoon, K. Buchanan, and M. V. 
Johnston. 1985. Choline aeetyltransferase activity in striatom of neonatal 
rats increased by nerve growth factor. Science (Wash.  DC). 229:284-- 
287. 
33. Mutoh, T., B. B. Rudkin, S. Koizumi, and G. Guroff. 1988. Nerve growth 
factor, a differentiating agent, and epidermal growth factor, a mitogen, 
increase the activities of different $6 kinases in PC 12 cells. J. Biol.  Chem. 
263:15853-15856. 
34. Romano, C., R. A. Nichols, P. Greengard, and L. A. Greene. 1987. Synap- 
sin 1 in PCI2 cells. I. Characterization of the phosphoprotein and effect 
of chronic NGF treatment. J.  Neurosci.  7:1294-1299. 
35. Rowland, E. A., T. H. Miiller, M. Goldstein, and L. A. Greene.  1987. 
Cell-free detection and characterization of a novel nerve growth factor- 
activated protein kinase in PCI2 cells. J. Biol.  Chem.  262:7504-7513. 
36. Rowland,  Gagn~,  E.,  and  L.  A.  Greene.  1989.  Multiple pathways of 
N-kinase activation in PCI2 cells. J. Neurochem.  In press. 
37. Seeley, P. J., A. Rukenstein, J.  L. Connoily, and L. A. Greene.  1984. 
Differential  inhibition of nerve growth factor and epidermal growth factor 
effects on the PCI2 pheochromocytoma line. J.  Cell Biol.  98:417-426. 
38. Van Buskirk, R., T. Corcoran, and J. A. Wagner. 1985. Clonal variants 
of PCI2 pheochromocytoma cells with defects in cAMP-dependent pro- 
tein kinases induce ornithine decarboxylase in response to nerve growth 
factor but not to adenosine agonists. Mol.  Cell.  Biol.  5:1984-1992. 
39. Volontt, C., and L. A. Greene.  1989.  Nerve growth factor responses by 
nonneuronal cells: detection by assay of a novel NGF-activated protein 
kinasc (PKN). Growth Factors. In press. 
40. Wotring, L. L., and J. L. Roti Roti. 1980. Thioguanine-inducnd  S and G2 
blocks and their significance to the mechanism of cytotoxicity. Cancer 
Res. 40:1458-1462. 
41. Zinn, K., A. Keller, L. A. Whittemore, and T. Maniatis. 1988. Aminopu- 
rine selectively inhibits the induction of 13-intefferon, c-fos and c-myc 
gene expression. Science (Wash.  DC). 240:210-213. 
Voiont8  et al. Purine Analogues Inhibit Responses to NGF  2403 